Accelerate Diagnostics Inc Kurs/ Buchwert
Was ist das Kurs/ Buchwert von Accelerate Diagnostics Inc?
Kurs/ Buchwert von Accelerate Diagnostics Inc ist -2.27
Was ist die Definition von Kurs/ Buchwert?
Kurs-Buchwert-Verhältnis repräsentiert das Verhältnis zwischen dem Aktienwert eines Unternehmens und dem Buchwert pro Aktie.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Kurs/ Buchwert von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Accelerate Diagnostics Inc
Was macht Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Unternehmen mit kurs/ buchwert ähnlich Accelerate Diagnostics Inc
- Aquis Entertainment hat Kurs/ Buchwert von -2.31
- Zelira Therapeutics hat Kurs/ Buchwert von -2.30
- Infinity Pharmaceuticals hat Kurs/ Buchwert von -2.29
- Acreage hat Kurs/ Buchwert von -2.28
- CytomX Therapeutics Inc hat Kurs/ Buchwert von -2.28
- Holista CollTech hat Kurs/ Buchwert von -2.27
- Accelerate Diagnostics Inc hat Kurs/ Buchwert von -2.27
- Bridgemarq Real Estate Services hat Kurs/ Buchwert von -2.27
- Biophytis SA hat Kurs/ Buchwert von -2.25
- Optiva hat Kurs/ Buchwert von -2.25
- Calumet hat Kurs/ Buchwert von -2.25
- Excellon Resources hat Kurs/ Buchwert von -2.25
- AA Plc hat Kurs/ Buchwert von -2.24